iSpecimen (NASDAQ:ISPC) Stock Price Down 4.6% – Here’s What Happened

iSpecimen Inc. (NASDAQ:ISPC)’s share price was down 4.6% during trading on Wednesday . The company traded as low as $0.3002 and last traded at $0.31. Approximately 446,345 shares changed hands during mid-day trading, a decline of 73% from the average daily volume of 1,653,262 shares. The stock had previously closed at $0.3250.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of iSpecimen in a report on Thursday, January 22nd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has an average rating of “Sell”.

iSpecimen Stock Down 4.6%

The stock has a 50-day moving average price of $0.35 and a 200 day moving average price of $0.73. The firm has a market capitalization of $3.03 million, a PE ratio of -0.04 and a beta of 1.84.

iSpecimen (NASDAQ:ISPC) last issued its quarterly earnings results on Monday, November 17th. The company reported ($0.48) earnings per share for the quarter, beating analysts’ consensus estimates of ($3.80) by $3.32. The firm had revenue of $0.11 million for the quarter, compared to analyst estimates of $3.33 million. iSpecimen had a negative net margin of 343.86% and a negative return on equity of 531.78%.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in iSpecimen stock. Scientech Research LLC purchased a new position in shares of iSpecimen Inc. (NASDAQ:ISPC) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 29,488 shares of the company’s stock, valued at approximately $38,000. Scientech Research LLC owned about 0.30% of iSpecimen at the end of the most recent reporting period. Institutional investors and hedge funds own 13.62% of the company’s stock.

About iSpecimen

iSpecimen, Inc (NASDAQ:ISPC) operates an online life sciences marketplace designed to connect researchers with human biological specimens and associated clinical data. The company’s platform streamlines the sourcing of biospecimens—such as plasma, serum, fresh and frozen tissue, saliva, urine and peripheral blood mononuclear cells (PBMCs)—by matching demand from pharmaceutical, biotechnology, diagnostic and academic organizations with supply from a wide network of clinical sites and biobanks.

Through its on-demand procurement model, iSpecimen provides customized specimen collection and fulfillment services that help accelerate research timelines and improve data quality.